@1littlecoder
developers & builders @nebiustf - Educator at https://t.co/BBKhRY0mTN Opinions are ChatGPTs
Tim Cook @tim_cookWe brought Touch to the Mac! From the all-new iPad mini to the 14-inch MacBook Pro and iMac... and now MacBook Pro with PROLED XDR Display and Touch, creators have new tools to do their best work yet.
Nebius Token Factory @nebiustfCached tokens are now live on Nebius Token Factory⚡ Reusing context across requests? Cached input can help reduce costs. See cached-token usage in API responses and billing, with pricing per model. More info:
Thariq @trq212experimenting with a lil personal project: an AI-native macOS dock with custom modes (writing, building, etc.) to help me stay focused my agent is able to customize mode behavior and add new modes, it uses jev to classify my activity + notifications in real time & act on them
Baidu AI @BaiduAI_NewsUnlimited OCR 2 is now open source. 📖✨ Built for virtually unlimited document parsing, it combines Sparse Reference Sliding Window Attention (SR-SWA) with Unlimited-Horizon Decoding to focus computation on the most relevant visual references while releasing KV caches that are no longer needed. Here’s what it delivers: • Nearly constant per-step decoding latency and memory footprint as documents grow • State-of-the-art results on MPDocBench and MarathonDocBench • On 100-page documents, 7.0× faster per-step decoding than Full Attention and 5.6× faster than R-SWA, with strong parsing accuracy maintained on documents up to 300 pages Explore it on GitHub. 👇
OpenAI @OpenAIGPT-6.1 Terra: delivering fast and capable computer use at a lower price. GPT-6.1 Terra understands what’s on screen, takes action across apps, writes naturally, and is a more capable model for your whole workday with the efficiency to take on more of it.
The Kobeissi Letter @KobeissiLetterBREAKING: Anthropic officially files its S-1 registration statement for an IPO, seeking to list on the Nasdaq under the ticker symbol $ANT. FULL SUMMARY OF ANTHROPIC'S S-1 FILING: 1. Anthropic posted H1 2026 revenue of $16.3 billion with a net loss of $80.7 billion 2. Anthropic says it does not expect to pay a dividend "in the foreseeable future" 3. Expects to spend up to $120.5 billion on SpaceXAI and Nvidia compute 4. Expects to spend up to $114.5 billion with Google through 2033 5. Revenue growth rate "may not be sustainable" and "may decrease" 6. May be required to seek additional financing "sooner than expected" 7. 5% of Anthropic's shares will go to the "Anthropic Public Benefit Fund" 8. S-1 includes warnings of AI's "catastrophic existential risks to humanity" Markets currently expect Anthropic to raise as much as $100 billion at a valuation of ~$2 trillion. The company is reportedly targeting an IPO in the week of November 16th.
Anthropic @AnthropicAIAnthropic has filed an S-1 registration statement with the SEC related to its proposed IPO. Read more: Legal disclaimer: A registration statement relating to these securities has been filed with the SEC but has not yet become effective. These securities may not be sold, nor may offers to buy be accepted, prior to the time the registration statement becomes effective. This post does not constitute an offer to sell or the solicitation of an offer to buy these securities, nor shall there be any sale of these securities in any state or jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such state or jurisdiction.
Anthropic @AnthropicAIAnthropic has filed an S-1 registration statement with the SEC related to its proposed IPO. Read more: Legal disclaimer: A registration statement relating to these securities has been filed with the SEC but has not yet become effective. These securities may not be sold, nor may offers to buy be accepted, prior to the time the registration statement becomes effective. This post does not constitute an offer to sell or the solicitation of an offer to buy these securities, nor shall there be any sale of these securities in any state or jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such state or jurisdiction.
Thariq @trq212@lydiahallie wait is it just me or is Opus 5.5 dumber
lyra @_lyraaaa_if you have a qwen3.5 4b around, please try steering neurons L14 N8949 +1 and L13 N7956 -1 now you have evil qwen recipe: dose × median(‖resid‖ leaving layer L, tokens 1:) / ‖W_down[:, n]‖` at the down_proj at every input
Tech God @tgod34748Looks like the iPhone Duo did not survive JerryRigEverything’s bend test 😬
swyx @swyxthis is my quant
Loubna Ben Allal @LoubnaBenAllal1Introducing Carbon-X: The best open DNA model. We midtrained a 14B model on DNA and text, and it beats every open language model and matches GPT-6.1 Sol at 1,000x lower cost. Ask it about a sequence, what a mutation does, or to generate new DNA.
Tim Pan @mediastorm_eniPhone Duo Review: 10,000 Folds Later...
Nebius @nebiusai“Startup companies like Nebius are doing incredibly well.” - @JensenHuang, @nvidia CEO at #NVIDIAGTC Berlin keynote
fal @falIntroducing FLUX 3 Max, the latest post-trained video model from fal Research in partnership with @bfl_ai. FLUX 3 Max is tied for #1 in image-to-video quality on independent third-party benchmarks, generating a 10-second, 720/768p video in ~12 seconds. For the next three weeks, FLUX 3 Max is 75% off, making it the most affordable frontier video model at its quality level.
Tanishq Mathew Abraham, Ph.D. @iScienceLuvrCancer patients with the same diagnosis often have very different tumor biology. Molecular testing can reveal underlying differences, but that's slow and expensive. Introducing Holon-S1, our platform to predict genes and biomarkers from routine pathology slides. • beats two other models at predicting spatial gene activity in a controlled comparison • has identified potentially novel biomarkers in breast cancer and colon cancer • evaluated across 16 organ types and more than 15 scanners, using slides from both formalin-fixed, paraffin-embedded and fresh-frozen tissue. We believe Holon-S1 has the potential to help researchers find new biomarkers in slides they already have, discover treatment targets, and bring more personalized cancer care within reach!
